Chauhan Jyoti 4
4 · Landos Biopharma, Inc. · Filed Feb 3, 2021
Insider Transaction Report
Form 4
Chauhan Jyoti
ED, Global Clinical Operations
Transactions
- Award
Stock Option (right to buy)
2021-02-03+250,604→ 250,604 totalExercise: $16.00Exp: 2031-02-02→ Common Stock (250,604 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying this option vested and became exercisable as to 25% of the shares underlying this option on January 26, 2021, an additional 25% of the shares underlying this option will vest and become exercisable on January 26, 2022, and the remaining 50% thereafter in 24 equal monthly installments, subject to the Reporting Person's continuous service with the Issuer on each such date.